Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
39 pending office actions • 26 art units • 39 examiners • 0 of 39 (0%) have an AI response strategy ready • 46 patents granted in the last 365 days
Ajou University Industry-Academic Cooperation Foundation manages 39 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 39 distinct examiners and 26 distinct art units. JIAJIA JANIE CAI is the busiest examiner for the foundation, currently overseeing 1 pending action. With 39 distinct examiners for 39 pending office actions, no examiner is currently handling more than one pending matter for the foundation.
The 26 distinct art units indicate that the foundation's biotechnology and pharmaceutical research is classified into many different specialized technical groups at the USPTO. This distribution across 26 distinct art units and 39 distinct examiners reflects a broad innovation strategy, requiring the foundation to navigate a wide range of individual examiner preferences and unit practices. The presence of 39 pending office actions demonstrates an active commitment to securing intellectual property. Having 39 distinct examiners means that the foundation's prosecution strategy must be highly adaptable to different examiner perspectives. The 26 distinct art units further emphasize the breadth of the foundation's technical reach.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (5%) |
| §101 + other | 12 (31%) |
| §103 only | 8 (21%) |
| §112 only | 4 (10%) |
| Multi-statute (no §101) | 12 (31%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CAI, JIAJIA JANIE | 1 | 29.1% | +20.7% |
| ALLEN, KYLA GUAN-PING TI | 1 | 89.0% | +16.7% |
| LAOBAK, ANDREW KEELAN | 1 | 75.4% | +34.5% |
| LEVY, MERRITT E | 1 | 32.3% | +33.5% |
| LYJAK, LORI LYNN | 1 | 89.9% | +8.6% |
| MISTRY, ONEAL R | 1 | 87.5% | +11.3% |
| ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1 | 0.0% | +0.0% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
| ZEROUAL, OMAR | 1 | 33.5% | +39.7% |
| BOWMAN, ANDREW J | 1 | 65.9% | +13.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18141086 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION | RICCI, CRAIG D | 190d overdue |
| 18032720 | OPTICAL SENSOR HAVING 2D-3D HETEROJUNCTION STRUCTURE AND MANUFACTURING METHOD THEREOF | REAMES, MATTHEW L | 42d overdue |
| 18265218 | PHOTO-CROSSLINKED HYALURONIC ACID BIO-INK FOR BIO-PRINTING, METHOD FOR PREPARING SAME, AND BIOLOGICAL STRUCTURE CAPABLE OF CONTROLLING PHYSICAL PROPERTIES USING SAME | KAUCHER, MARK S | 14d |
| 18274537 | BIO-SENSING DEVICE WITH OPTOELECTRONIC DEVICE | BRYANT, MICHAEL CASEY | 23d |
| 18322850 | SERUM EXOSOMAL SF3B4 MARKER COMPOSITION FOR DIAGNOSING EARLY STAGE HEPATOCELLULAR CARCINOMA FOR NONINVASIVE IN VITRO DIAGNOSIS | BELLAH, JEFFREY LAWRENCE | 40d |
| 17907791 | BIOMARKER COMPOSITION FOR DIAGNOSING DIFFUSE TYPE GASTRIC CANCER, AND MEDICAL USE THEREOF | KENNEDY, SARAH JANE | 72d |
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | — |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | — |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | — |
| 18997923 | PLASMA ETCHING METHOD USING HEPTAFLUOROPROPYL METHYL ETHER AND HEPTAFLUOROISOPROPYL METHYL ETHER | LAOBAK, ANDREW KEELAN | — |
| 19002314 | AUTONOMOUS VALET PARKING SYSTEM AND METHOD FOR OPERATING THE SAME | LEVY, MERRITT E | — |
| 18999698 | SYSTEM AND METHOD OF MEDICAL IMAGE QUALITY FEEDBACK | MISTRY, ONEAL R | — |
| 18855162 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC STROKE, CONTAINING RAGE ANTAGONIST AND AGE SCAVENGER | WHITE, DAWANNA SHAR-DAY | — |
| 18901173 | METHOD FOR ACHIEVING CARBON NEUTRALITY BASED ON ESG IN INDUSTRIAL SITES AND APPARATUS THEREOF | ZEROUAL, OMAR | — |
| 18898326 | SURFACE MODIFICATION METHOD OF ZIRCONIA MATERIAL USING VACUUM PLASMA | BOWMAN, ANDREW J | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1683 | 2 |
| 1717 | 1 |
| 3663 | 1 |
| 3612 | 1 |
| 3628 | 1 |
| 1741 | 1 |
| 1655 | 1 |
| 1785 | 1 |
| 2443 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | 1717 | §103 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | — | §103§112 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 18997923 | PLASMA ETCHING METHOD USING HEPTAFLUOROPROPYL METHYL ETHER AND HEPTAFLUOROISOPROPYL METHYL ETHER | LAOBAK, ANDREW KEELAN | — | §103§112 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 19002314 | AUTONOMOUS VALET PARKING SYSTEM AND METHOD FOR OPERATING THE SAME | LEVY, MERRITT E | 3663 | §103§112 | Non-Final OA | — | Pending | Dec 26, 2024 |
| 19001929 | VEHICLE FOR PERFORMING MINIMAL RISK MANEUVER AND METHOD OF OPERATING THE SAME | LYJAK, LORI LYNN | 3612 | — | Final Rejection | — | Pending | Dec 26, 2024 |
| 18999698 | SYSTEM AND METHOD OF MEDICAL IMAGE QUALITY FEEDBACK | MISTRY, ONEAL R | — | §101§102§103 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18982276 | METHOD FOR PRODUCING INNER EAR ORGANOIDS USING RETINOIC ACID AND INNER EAR ORGANOIDS PRODUCED BY THE METHOD | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | — | §101§102§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18855162 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC STROKE, CONTAINING RAGE ANTAGONIST AND AGE SCAVENGER | WHITE, DAWANNA SHAR-DAY | — | §102§103 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18901173 | METHOD FOR ACHIEVING CARBON NEUTRALITY BASED ON ESG IN INDUSTRIAL SITES AND APPARATUS THEREOF | ZEROUAL, OMAR | 3628 | §103§112 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18898326 | SURFACE MODIFICATION METHOD OF ZIRCONIA MATERIAL USING VACUUM PLASMA | BOWMAN, ANDREW J | 1741 | §103 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18746307 | METHOD AND APPARATUS FOR IMPROVING HYPERVISOR PERFORMANCE IN MEMORY DISAGGREGATION ENVIRONMENT | CASTANEDA, IVAN ALEXANDER | — | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18720453 | ANTI-STRESS COMPOSITION COMPRISING NATURAL EXTRACT MIXTURE, AND USE THEREOF | CHEN, CATHERYNE | 1655 | §101§102 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18700307 | COMPOSITION FOR DIAGNOSING PERIODONTAL DISEASES BY USING BACTERIAL CLUSTERS IN GINGIVAL CREVICULAR FLUID, AND USE THEREOF | DAUNER, JOSEPH G | — | §101§102§103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18700295 | COMPOSITION FOR DIAGNOSING PERIODONTAL DISEASE USING BACTERIAL POPULATION IN SALIVA, AND USE THEREOF | BUCHANAN, BAILEY CHEYENNE | — | §101§103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18699246 | SURFACE-MODIFIED DENTAL ZIRCONIA MATERIAL AND METHOD FOR PREPARING SAME | WEDDLE, ALEXANDER MARION | 1785 | §102§103 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18595389 | FEDERATED LEARNING METHOD AND DEVICE USING DEVICE CLUSTERING | ELL, MATTHEW | — | §101§103 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18687542 | PEPTIDE FOR DETECTING CA125 AND USE THEREOF | STEPHENS, AMELIA CAROLE | — | §101§112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18290613 | CELL-PENETRATING DEGRADING ANTIBODY THAT PENETRATES INTO CELLS TO DEGRADE AND REMOVE TARGET PROTEIN AND USE THEREOF | HOLTZMAN, KATHERINE ANN | — | §112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18397144 | METHOD AND SYSTEM FOR NETWORK SECURITY SITUATION ASSESSMENT | GREENE, JOSEPH L | 2443 | §103 | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18561470 | PHARMACEUTICAL COMPOSITION COMPRISING HYALURONIC ACID COMPLEX FOR PREVENTION OR TREATMENT OF SKIN DISEASE | CREWS, JARET JAMES | 1691 | §103§112 | Final Rejection | — | Pending | Nov 16, 2023 |
| 18486506 | MONITORING SYSTEM AND METHOD OF HYDROGEN REFUELING STATION AND COMPUTING DEVICE FOR EXECUTING THE SAME | PARK, HYUN D | 2857 | §101 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18476715 | ELECTRONIC DEVICE FOR PROVIDING REAL-TIME EMOTIONAL FEEDBACK TO USER'S WRITING, METHOD THEREOF AND CLASSIFICATION SEVER FOR ANALYZING REAL-TIME EMOTIONAL FEEDBACK | WEAVER, ADAM MICHAEL | 2658 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18472987 | COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR | MARCSISIN, ELLEN JEAN | 1677 | §101§102§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18281460 | TARGET ANALYTE DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION | HOWARD, ZACHARY C | 1674 | §101§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18244044 | METHOD AND APPARATUS FOR CHECKING OF MENTAL HEALTH USING CONTENTS | ANTOINE, LISA HOPE | 3715 | §101§103 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18266581 | METHOD FOR CONFIGURING UAV NETWORK BY UTILIZING MULTIMODAL SENSOR INFORMATION | JAVAID, JAMAL | 2412 | §103 | Non-Final OA | 30d | Pending | Aug 03, 2023 |
| 18274537 | BIO-SENSING DEVICE WITH OPTOELECTRONIC DEVICE | BRYANT, MICHAEL CASEY | 2884 | §103§112 | Non-Final OA | 23d | Pending | Jul 27, 2023 |
| 18344488 | PLASMA TREATMENT DEVICE | HALL, DEANNA K | 3783 | §103 | Non-Final OA | 33d | Pending | Jun 29, 2023 |
| 18265218 | PHOTO-CROSSLINKED HYALURONIC ACID BIO-INK FOR BIO-PRINTING, METHOD FOR PREPARING SAME, AND BIOLOGICAL STRUCTURE CAPABLE OF CONTROLLING PHYSICAL PROPERTIES USING SAME | KAUCHER, MARK S | 1764 | §102§103 | Final Rejection | 14d | Pending | Jun 02, 2023 |
| 18322850 | SERUM EXOSOMAL SF3B4 MARKER COMPOSITION FOR DIAGNOSING EARLY STAGE HEPATOCELLULAR CARCINOMA FOR NONINVASIVE IN VITRO DIAGNOSIS | BELLAH, JEFFREY LAWRENCE | 1683 | §101§103 | Final Rejection | 40d | Pending | May 24, 2023 |
| 18141086 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION | RICCI, CRAIG D | 1611 | §101§103§112 | Non-Final OA | 190d overdue | Pending | Apr 28, 2023 |
| 18032720 | OPTICAL SENSOR HAVING 2D-3D HETEROJUNCTION STRUCTURE AND MANUFACTURING METHOD THEREOF | REAMES, MATTHEW L | 2896 | §102§103§112 | Non-Final OA | 42d overdue | Pending | Apr 19, 2023 |
| 18025833 | ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF | ROONEY, NORA MAUREEN | 1641 | §112 | Final Rejection | — | Pending | Mar 10, 2023 |
| 17979965 | SECURITY MANAGEMENT METHOD AND SYSTEM FOR BLENDED ENVIRONMENT | OSMAN, RAMY M | 2457 | §103 | Final Rejection | — | Pending | Nov 03, 2022 |
| 17967831 | COMPOSITION FOR PROMOTING ANGIOGENESIS USING LIQUID TYPE PLASMA AND METHOD FOR PROMOTING ANGIOGENESIS USING SAME | PRICE, NATHAN R | 3783 | §112 | Non-Final OA | 10d overdue | Pending | Oct 17, 2022 |
| 17907791 | BIOMARKER COMPOSITION FOR DIAGNOSING DIFFUSE TYPE GASTRIC CANCER, AND MEDICAL USE THEREOF | KENNEDY, SARAH JANE | 1682 | §103§112 | Non-Final OA | 72d | Pending | Aug 29, 2022 |
| 17777460 | COMPOSITION, COMPRISING COTL1 AS ACTIVE INGREDIENT, FOR DIAGNOSIS OF BONE DISEASE OR OBESITY | CORDAS, EMILY ANN | 1632 | §112 | Non-Final OA | — | Pending | May 17, 2022 |
| 17568321 | METHOD AND APPARATUS FOR TRACING FAULT OF COLLABORATIVE ROBOT | OSTROW, ALAN LINDSAY | 3657 | §101 | Final Rejection | — | Pending | Jan 04, 2022 |
| 17282650 | TARGET NUCLEIC ACID DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION | POHNERT, STEVEN C | 1683 | §103 | Final Rejection | — | Pending | Apr 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial